1,296
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer

, , , , , , & show all
Pages 1154-1169 | Received 12 Apr 2018, Accepted 15 May 2018, Published online: 25 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Xue-Tao Li, Ming Jing, Fu-Yi Cai, Xue-Min Yao, Liang Kong & Xiao-Bo Wang. (2021) Enhanced antitumour efficiency of R8GD-modified epirubicin plus tetrandrine liposomes in treatment of gastric cancer via inhibiting tumour metastasis. Journal of Liposome Research 31:2, pages 145-157.
Read now
Xiu-ying Li, Jian-hua Wang, Li-yan Gu, Xue-min Yao, Fu-yi Cai, Ming Jing, Xue-tao Li & Rui-jun Ju. (2020) Dual variable of drug loaded micelles in both particle and electrical charge on gastric cancer treatment. Journal of Drug Targeting 28:10, pages 1071-1084.
Read now
Ming Jing, Xiao-Jie Bi, Xue-Min Yao, Fuyi Cai, Jing-Jing Liu, Min Fu, Liang Kong, Xin-Ze Liu, Lu Zhang, Si-Yu He, Lian-Qun Jia & Xue-Tao Li. (2020) Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis. Drug Development and Industrial Pharmacy 46:4, pages 621-634.
Read now
Min Fu, Wei Tang, Jing-Jing Liu, Xiao-Qing Gong, Liang Kong, Xue-Min Yao, Ming Jing, Fu-Yi Cai, Xue-Tao Li & Rui-Jun Ju. (2020) Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer. Journal of Drug Targeting 28:3, pages 245-258.
Read now
Xiuying Li, Luanxia Shi, Yandong Li, Qinqing Li, Xiujun Duan, Yingli Wang & Qingshan Li. (2020) The enhanced treatment efficacy of invasive brain glioma by dual-targeted artemether plus paclitaxel micelles. Artificial Cells, Nanomedicine, and Biotechnology 48:1, pages 983-996.
Read now
Hong-Jun Xie, Jing Zhao, DongZhi Zhuo-Ma, NorBu Zhan-Dui, Aga Er-Bu & Tashi Tsering. (2019) Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3465-3477.
Read now
Jing-Jing Liu, Wei Tang, Min Fu, Xiao-Qing Gong, Liang Kong, Xue-Min Yao, Ming Jing, Fu-Yi Cai, Xue-Tao Li & Rui-Jun Ju. (2019) Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1947-1960.
Read now

Articles from other publishers (9)

Parteek Prasher, Rabab Fatima, Mousmee Sharma, Bekzat Tynybekov, Asma M. Alshahrani, Dilek Arslan Ateşşahin, Javad Sharifi-Rad & Daniela Calina. (2023) Honokiol and its analogues as anticancer compounds: Current mechanistic insights and structure-activity relationship. Chemico-Biological Interactions 386, pages 110747.
Crossref
Siqi Wu, Zhe Sun, Zehuai Guo, Peiqin Li, Qianqian Mao, Yang Tang, Hongyu Chen, Huiting Peng, Sisi Wang & Yang Cao. (2023) The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines (BAST) in lung cancer progression-a comprehensive review. Journal of Ethnopharmacology 314, pages 116565.
Crossref
Lu Zhang, Liang Kong, Si-yu He, Xin-ze Liu, Yang Liu, Juan Zang, Rui-jun Ju & Xue-tao Li. (2021) The anti-ovarian cancer effect of RPV modified paclitaxel plus schisandra B liposomes in SK-OV-3 cells and tumor-bearing mice. Life Sciences 285, pages 120013.
Crossref
Kai Niu, Xie-Wan Chen, Yu Qin, Lu-Ping Zhang, Rong-Xia Liao & Jian-Guo Sun. (2021) Celecoxib Blocks Vasculogenic Mimicry via an Off-Target Effect to Radiosensitize Lung Cancer Cells: An Experimental Study. Frontiers in Oncology 11.
Crossref
Yuehai Pan, Shuai Zhao & Fan Chen. (2021) The potential value of dequalinium chloride in the treatment of cancer: Focus on malignant glioma. Clinical and Experimental Pharmacology and Physiology 48:4, pages 445-454.
Crossref
Hiren Khatri, Nimitt Chokshi, Shruti Rawal, Bhoomika M. Patel, Murali Badanthadka & Mayur M. Patel. (2020) Fabrication and in vivo evaluation of ligand appended paclitaxel and artemether loaded lipid nanoparticulate systems for the treatment of NSCLC: A nanoparticle assisted combination oncotherapy. International Journal of Pharmaceutics 583, pages 119386.
Crossref
Sanya Haiaty, Mohammad‐Reza Rashidi, Maryam Akbarzadeh, Nazila F. Maroufi, Bahman Yousefi & Mohammad Nouri. (2020) Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy. IUBMB Life 72:5, pages 825-841.
Crossref
Liang Kong, Fu‐yi Cai, Xue‐min Yao, Ming Jing, Min Fu, Jing‐jing Liu, Si‐yu He, Lu Zhang, Xin‐ze Liu, Rui‐jun Ju & Xue‐tao Li. (2020) RPV‐modified epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply. Cancer Science 111:2, pages 621-636.
Crossref
Chon Phin Ong, Wai Leong Lee, Yin Quan Tang & Wei Hsum Yap. (2019) Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers 12:1, pages 48.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.